BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 30078747)

  • 1. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
    Kahles A; Lehmann KV; Toussaint NC; Hüser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; ; Rätsch G
    Cancer Cell; 2018 Aug; 34(2):211-224.e6. PubMed ID: 30078747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genome-wide analysis of the determinants of RNA splicing in kidney renal clear cell carcinoma.
    Lehmann KV; Kahles A; Kandoth C; Lee W; Schultz N; Stegle O; Rätsch G
    Pac Symp Biocomput; 2015; 20():44-55. PubMed ID: 25592567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
    Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
    BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional Variation of Splicing QTLs in Human Brain.
    Zhang Y; Yang HT; Kadash-Edmondson K; Pan Y; Pan Z; Davidson BL; Xing Y
    Am J Hum Genet; 2020 Aug; 107(2):196-210. PubMed ID: 32589925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Allele-Specific Alternative Splicing from Population-Scale RNA-Seq Data.
    Demirdjian L; Xu Y; Bahrami-Samani E; Pan Y; Stein S; Xie Z; Park E; Wu YN; Xing Y
    Am J Hum Genet; 2020 Sep; 107(3):461-472. PubMed ID: 32781045
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
    Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet
    Rondina MT; Voora D; Simon LM; Schwertz H; Harper JF; Lee O; Bhatlekar SC; Li Q; Eustes AS; Montenont E; Campbell RA; Tolley ND; Kosaka Y; Weyrich AS; Bray PF; Rowley JW
    Circ Res; 2020 Feb; 126(4):501-516. PubMed ID: 31852401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing related genetic variants contribute to bladder cancer risk.
    Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z
    Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.
    Cheng R; Xu Z; Luo M; Wang P; Cao H; Jin X; Zhou W; Xiao L; Jiang Q
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35279714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
    Nejo T; Wang L; Leung KK; Wang A; Lakshmanachetty S; Gallus M; Kwok DW; Hong C; Chen LH; Carrera DA; Zhang MY; Stevers NO; Maldonado GC; Yamamichi A; Watchmaker PB; Naik A; Shai A; Phillips JJ; Chang SM; Wiita AP; Wells JA; Costello JF; Diaz AA; Okada H
    Sci Rep; 2024 Mar; 14(1):6362. PubMed ID: 38493204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene.
    Saferali A; Yun JH; Parker MM; Sakornsakolpat P; Chase RP; Lamb A; Hobbs BD; Boezen MH; Dai X; de Jong K; Beaty TH; Wei W; Zhou X; Silverman EK; Cho MH; Castaldi PJ; Hersh CP; ;
    PLoS Genet; 2019 Jul; 15(7):e1008229. PubMed ID: 31269066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating alternative splicing and mRNA editing into the genetic analysis of complex traits.
    Hassan MA; Saeij JP
    Bioessays; 2014 Nov; 36(11):1032-40. PubMed ID: 25171292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
    Ruggles KV; Tang Z; Wang X; Grover H; Askenazi M; Teubl J; Cao S; McLellan MD; Clauser KR; Tabb DL; Mertins P; Slebos R; Erdmann-Gilmore P; Li S; Gunawardena HP; Xie L; Liu T; Zhou JY; Sun S; Hoadley KA; Perou CM; Chen X; Davies SR; Maher CA; Kinsinger CR; Rodland KD; Zhang H; Zhang Z; Ding L; Townsend RR; Rodriguez H; Chan D; Smith RD; Liebler DC; Carr SA; Payne S; Ellis MJ; Fenyő D
    Mol Cell Proteomics; 2016 Mar; 15(3):1060-71. PubMed ID: 26631509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer repository of validated natural and cryptic mRNA splicing mutations.
    Shirley BC; Mucaki EJ; Rogan PK
    F1000Res; 2018; 7():1908. PubMed ID: 31275557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP Inhibitors.
    Chevalier LM; Billaud A; Fronteau S; Dauvé J; Patsouris A; Verriele V; Morel A
    Mol Diagn Ther; 2020 Apr; 24(2):233-243. PubMed ID: 32124385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
    Bjørklund SS; Panda A; Kumar S; Seiler M; Robinson D; Gheeya J; Yao M; Alnæs GIG; Toppmeyer D; Riis M; Naume B; Børresen-Dale AL; Kristensen VN; Ganesan S; Bhanot G
    Sci Rep; 2017 Jul; 7(1):5568. PubMed ID: 28717182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
    Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; ; Buonamici S; Yu L
    Cell Rep; 2018 Apr; 23(1):282-296.e4. PubMed ID: 29617667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
    Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
    Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
    Tanimoto K; Muramatsu T; Inazawa J
    Cancer Med; 2019 Dec; 8(17):7372-7384. PubMed ID: 31631560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.